These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 39122489)
1. Efficacy of Fractional Versus Fully Ablative CO Gnesotto L; Piraccini BM; Starace M; Naldi L; Mioso G; Sechi A Dermatol Pract Concept; 2024 Jul; 14(3):. PubMed ID: 39122489 [TBL] [Abstract][Full Text] [Related]
2. Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis. El-Tatawy RA; Aliweh HA; Hegab DS; Talaat RAZ; Shams Eldeen MA Lasers Med Sci; 2019 Dec; 34(9):1873-1880. PubMed ID: 31025207 [TBL] [Abstract][Full Text] [Related]
3. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. Gupta AK; Fleckman P; Baran R J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136 [TBL] [Abstract][Full Text] [Related]
4. Fractional CO Zaki AM; Abdo HM; Ebadah MA; Ibrahim SM Dermatol Ther; 2020 Jan; 33(1):e13155. PubMed ID: 31697010 [TBL] [Abstract][Full Text] [Related]
5. Comparative Study of Traditional Ablative CO Rajbanshi B; Shen L; Jiang M; Gao Q; Huang X; Ma J; Wang J; Hu Y; Lv H; Wu X; Zhao J Clin Drug Investig; 2020 Jun; 40(6):575-582. PubMed ID: 32314298 [TBL] [Abstract][Full Text] [Related]
6. Treatment of onychomycosis using a 1064-nm diode laser with or without topical antifungal therapy: a single-center, retrospective analysis in 56 patients. Weber GC; Firouzi P; Baran AM; Bölke E; Schrumpf H; Buhren BA; Homey B; Gerber PA Eur J Med Res; 2018 Oct; 23(1):53. PubMed ID: 30355363 [TBL] [Abstract][Full Text] [Related]
7. Real-world effectiveness of a fractional CO Lee SK; Kim HY; Lee JH; Lee UH; Kim MS Dermatol Ther; 2022 Jun; 35(6):e15498. PubMed ID: 35388594 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of safety and efficacy of combination therapy of fractional CO Shetty P; Rangegowda SM; Vinay KN; Ravikumar BC; Nagesha PC Lasers Med Sci; 2023 Jun; 38(1):147. PubMed ID: 37354212 [TBL] [Abstract][Full Text] [Related]
9. Fractional CO2 laser - assisted methylene blue photodynamic therapy is a potential alternative therapy for onychomycosis in the era of antifungal resistance. Sobhy N; Talla Eweed H; Omar SS Photodiagnosis Photodyn Ther; 2022 Dec; 40():103149. PubMed ID: 36228978 [TBL] [Abstract][Full Text] [Related]
10. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. Del Rosso JQ J Clin Aesthet Dermatol; 2014 Jul; 7(7):10-8. PubMed ID: 25053979 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of fractional carbon dioxide (CO Shi J; Li J; Huang H; Permatasari F; Liu J; Xu Y; Wu D; Zhou BR; Luo D J Cosmet Laser Ther; 2017 Oct; 19(6):353-359. PubMed ID: 28557542 [TBL] [Abstract][Full Text] [Related]
12. Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream. Lim EH; Kim HR; Park YO; Lee Y; Seo YJ; Kim CD; Lee JH; Im M J Am Acad Dermatol; 2014 May; 70(5):918-23. PubMed ID: 24655819 [TBL] [Abstract][Full Text] [Related]
13. Fractional CO2 laser with topical 1% terbinafine cream versus oral itraconazole in the management of onychomycosis: A randomized controlled trial. Ranjan E; Arora S; Sharma N Indian J Dermatol Venereol Leprol; 2023; 89(1):47-53. PubMed ID: 35389015 [TBL] [Abstract][Full Text] [Related]
14. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study. Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847 [TBL] [Abstract][Full Text] [Related]
15. Fractional CO Abdallah M; Abu-Ghali MM; El-Sayed MT; Soltan MY J Dermatolog Treat; 2022 Feb; 33(1):542-549. PubMed ID: 32419540 [TBL] [Abstract][Full Text] [Related]
16. Fractional carbon-dioxide (CO2) laser-assisted topical therapy for the treatment of onychomycosis. Bhatta AK; Keyal U; Huang X; Zhao JJ J Am Acad Dermatol; 2016 May; 74(5):916-23. PubMed ID: 26874820 [TBL] [Abstract][Full Text] [Related]
17. Carbon Dioxide Laser Plus Topical 5% Luliconazole: A Better Combination Therapeutic Modality for Onychomycosis. Bashir S; Hassan I; Mubashir S J Cutan Aesthet Surg; 2021; 14(3):318-322. PubMed ID: 34908774 [TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis. Paul C; Coustou D; Lahfa M; Bulai-Livideanu C; Doss N; Mokthar I; Turki H; Nouira R; Fazaa B; Ben Osman A; Zourabichvili O; Cazeau C; Coubetergues H; Picot S; Bienvenu AL; Voisard JJ Dermatology; 2013; 227(2):157-64. PubMed ID: 24051622 [TBL] [Abstract][Full Text] [Related]
19. Ciclopirox nail lacquer solution 8% in the 21st century. Gupta AK; Baran R J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S96-102. PubMed ID: 11051138 [TBL] [Abstract][Full Text] [Related]
20. Ciclopirox nail lacquer: a brush with onychomycosis. Gupta AK Cutis; 2001 Aug; 68(2 Suppl):13-6. PubMed ID: 11665723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]